Sign up to access historical data
Similar companies
Company | Transaction Value | |
---|---|---|
PfizerPFE |
-$140,000 | |
ZomedicaZOM |
$4.1M | |
Johnson & JohnsonJNJ |
-$127M | |
Mind Medicine (MindMed)MNMD |
-$45M | |
ModernaMRNA |
-$334B |
Insider Transactions
Name | Transaction Date | Sold / Bought | Shares | Price | Value |
---|---|---|---|---|---|
SHAH JAISIM | Oct 29, 2024 | Buy | 32,000 | $0.9897 | $32,000 |
Followwill Dorman | Oct 18, 2024 | Buy | 1,000 | $0.99 | $990 |
Chun Jay | Oct 18, 2024 | Buy | 5,000 | $0.95 | $4,800 |
Wu Yue Alexander | Oct 17, 2024 | Buy | 20,000 | $0.9496 | $19,000 |
Ji Henry | Oct 17, 2024 | Buy | 10,000 | $0.971 | $9,700 |
Lemus David | Oct 17, 2024 | Buy | 2,000 | $0.9 | $1,800 |
SHAH JAISIM | Oct 16, 2024 | Buy | 30,000 | $0.9917 | $30,000 |
Ma Stephen Hoi | Oct 16, 2024 | Buy | 6,700 | $0.97 | $6,500 |
Ji Henry | May 17, 2024 | Buy | 50,000 | $0.8797 | $44,000 |
Chun Jay | May 17, 2024 | Buy | 57,500 | $0.8981 | $52,000 |
SHAH JAISIM | May 17, 2024 | Buy | 56,939 | $0.915 | $52,000 |
Ma Stephen Hoi | May 17, 2024 | Buy | 14,140 | $0.88 | $12,000 |
SHAH JAISIM | May 16, 2024 | Buy | 83,061 | $0.8409 | $70,000 |
Sorrento Therapeutics, Inc. | Sep 21, 2023 | Sell | 60,068,585 | $0 | $0 |
Sorrento Therapeutics, Inc. | Sep 21, 2023 | Sell | 4,490,617 | $0 | $0 |
Sorrento Therapeutics, Inc. | Dec 2, 2022 | Buy | 224,841 | $0.3507 | $79,000 |
Sorrento Therapeutics, Inc. | Nov 25, 2022 | Buy | 46,172 | $0.4374 | $20,000 |
Sorrento Therapeutics, Inc. | Nov 23, 2022 | Buy | 442,829 | $0.3967 | $180,000 |
Sorrento Therapeutics, Inc. | Nov 22, 2022 | Buy | 672,775 | $0.226 | $150,000 |
What's the latest insider transaction for Scilex Holding?
The most recent insider transaction for Scilex Holding was conducted by SHAH JAISIM, who sold 32,000 shares on October 29, 2024 at a price of $0.99 per share.
Which insider bought the most SCLX stock over the last two years?
Sorrento Therapeutics, Inc. has bought the most SCLX stock in the last 2 years, with a total value of $430,000.
What is the total value of insider transactions for Scilex Holding (SCLX) in the last 2 years?
According to our estimates, the total value of insider transactions for Scilex Holding in the last 2 years is positive, amounting to $760,000. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
How do insider transactions over the last 2 years reflect on Scilex Holding's market confidence?
Over the last 2 years, insider transactions for Scilex Holding have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the insiders' view on the company's valuation and growth potential.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.